Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen
Clinical trial NCT02285114 · COMPLETED
Trial details
- NCT number
- NCT02285114
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-20
- Primary completion
- 2019-11-04
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.